Therapeutic potential of adult stem cells-derived mitochondria transfer combined with curcumin administration into ARPE-19 cells in age-related macular degeneration model
Özet
Objective: Mitochondria transfer from human Wharton's Jelly-derived mesenchymal stem cells (hWJ-MSCs-mt) and human endometrium-derived mesenchymal stem cells (hE-MSCs-mt), along with curcumin, were explored as potential treatments for age-related macular degeneration (AMD) caused by mitochondrial inefficiency, using a retinal model to assess impacts of curcumin and hWJ-MSCs-mt or hE-MSCs-mt on AMD. Methods: ARPE-19 cells established an in vitro AMD model. Cells were exposed to 0–50 μM curcumin for 24 hours to determine optimal concentration by assessing their viability. Immunofluorescence examined SOD1, TNF-α, and TGF-β levels at optimal hydrogen peroxide (H2O2) concentration. β-galactosidase staining and DCFH analysis evaluated H2O2-induced cellular senescence. Immunofluorescence assessed REP65, CRALBP1 (RLBP1), Pink1, and Parkin expression, whereas qRT-PCR analyzed Nrf2, Ire1a, ARMS2, HTRA1, RPE65, RLBP1, NOX4, and TOMM20 expression following co-treatment with curcumin and hWJ-MSCs-mt or hE-MSCs-mt. Results: Curcumin improved ARPE-19 cell survival under H2O2-induced oxidative stress by regulating SOD1, TNF-α, TGF-β, DCFH, and MDA levels. hWJ-MSCs-mt transfer increased RLBP1 and Parkin expression, whereas curcumin reduced Parkin expression. hE-MSCs-mt transfer upregulated Parkin, RPE65, Pink1, and RLBP1 expressions, with curcumin enhancing RPE65 expression. hWJ-MSCs-mt and curcumin combined more effectively downregulated expressions of stress-related genes (Nrf2, Ire1α, NOX4) and improved expression of mitochondrial function gene (TOMM20). hE-MSCs-mt transfer with curcumin synergistically enhanced expression of retinal health markers (RPE65, RLBP1) and downregulated expression of damage-associated genes (HTRA1, ARMS2) in AMD models. Conclusion: Curcumin combined with hWJ-MSCs-mt or hE-MSCs-mt is a potential AMD therapy owing to its anti-inflammatory properties; however, further in vivo and human studies are needed to confirm its efficacy and safety.
Anahtar Kelimeler
- Scopus
- 12
- WoS
- 12
- OpenAlex
- 15
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Kılıç, Kamil Can | |
| dc.contributor.author | Duruksu, Gökhan | |
| dc.contributor.author | Öztürk, Ahmet | |
| dc.contributor.author | Rençber, Selenay Furat | |
| dc.contributor.author | Kılıç, Buket | |
| dc.contributor.author | Yazır, Yusufhan | |
| dc.date.accessioned | 2026-10-27T23:47:38.621480412Z | |
| dc.date.available | 2026-10-27T23:47:38.621480412Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Objective: Mitochondria transfer from human Wharton's Jelly-derived mesenchymal stem cells (hWJ-MSCs-mt) and human endometrium-derived mesenchymal stem cells (hE-MSCs-mt), along with curcumin, were explored as potential treatments for age-related macular degeneration (AMD) caused by mitochondrial inefficiency, using a retinal model to assess impacts of curcumin and hWJ-MSCs-mt or hE-MSCs-mt on AMD. Methods: ARPE-19 cells established an in vitro AMD model. Cells were exposed to 0–50 μM curcumin for 24 hours to determine optimal concentration by assessing their viability. Immunofluorescence examined SOD1, TNF-α, and TGF-β levels at optimal hydrogen peroxide (H2O2) concentration. β-galactosidase staining and DCFH analysis evaluated H2O2-induced cellular senescence. Immunofluorescence assessed REP65, CRALBP1 (RLBP1), Pink1, and Parkin expression, whereas qRT-PCR analyzed Nrf2, Ire1a, ARMS2, HTRA1, RPE65, RLBP1, NOX4, and TOMM20 expression following co-treatment with curcumin and hWJ-MSCs-mt or hE-MSCs-mt. Results: Curcumin improved ARPE-19 cell survival under H2O2-induced oxidative stress by regulating SOD1, TNF-α, TGF-β, DCFH, and MDA levels. hWJ-MSCs-mt transfer increased RLBP1 and Parkin expression, whereas curcumin reduced Parkin expression. hE-MSCs-mt transfer upregulated Parkin, RPE65, Pink1, and RLBP1 expressions, with curcumin enhancing RPE65 expression. hWJ-MSCs-mt and curcumin combined more effectively downregulated expressions of stress-related genes (Nrf2, Ire1α, NOX4) and improved expression of mitochondrial function gene (TOMM20). hE-MSCs-mt transfer with curcumin synergistically enhanced expression of retinal health markers (RPE65, RLBP1) and downregulated expression of damage-associated genes (HTRA1, ARMS2) in AMD models. Conclusion: Curcumin combined with hWJ-MSCs-mt or hE-MSCs-mt is a potential AMD therapy owing to its anti-inflammatory properties; however, further in vivo and human studies are needed to confirm its efficacy and safety. | |
| dc.description.sponsorship | Kocaeli Üniversitesi, (TDK-2022-2826) | |
| dc.description.sponsorship | Kocaeli Üniversitesi | |
| dc.identifier.articlenumber | 102687 | |
| dc.identifier.doi | 10.1016/j.tice.2024.102687 | |
| dc.identifier.issn | 0040-8166 | |
| dc.identifier.pmid | 39705870 | |
| dc.identifier.scopus | 2-s2.0-85212423286 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/kostu/10568 | |
| dc.identifier.volume | 93 | |
| dc.identifier.wos | WOS:001393199600001 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Ltd | |
| dc.relation.ispartof | Tissue and Cell | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | ARPE-19 cells | |
| dc.subject | Curcumin | |
| dc.subject | Macular degeneration | |
| dc.subject | Mesenchymal stem cell | |
| dc.subject | Mitochondria | |
| dc.subject.classification | Anatomy & Morphology | |
| dc.subject.classification | Cell Biology | |
| dc.subject.other | Cell Line | |
| dc.subject.other | Curcumin | |
| dc.subject.other | Humans | |
| dc.subject.other | Hydrogen Peroxide | |
| dc.subject.other | Macular Degeneration | |
| dc.subject.other | Mesenchymal Stem Cells | |
| dc.subject.other | Mitochondria | |
| dc.subject.other | Models, Biological | |
| dc.subject.other | Retinal Pigment Epithelium | |
| dc.subject.other | age related maculopathy susceptibility 2 protein | |
| dc.subject.other | autophagy related protein | |
| dc.subject.other | beta galactosidase | |
| dc.subject.other | copper zinc superoxide dismutase | |
| dc.subject.other | dichlorodihydrofluorescein diacetate | |
| dc.subject.other | parkin | |
| dc.subject.other | protein IRE1 | |
| dc.subject.other | protein IRE1a | |
| dc.subject.other | protein pink1 | |
| dc.subject.other | reduced nicotinamide adenine dinucleotide phosphate oxidase 4 | |
| dc.subject.other | retinal pigment epithelium specific 65 | |
| dc.subject.other | retinaldehyde binding protein 1 | |
| dc.subject.other | retinoid binding protein | |
| dc.subject.other | serine protease HTRA1 | |
| dc.subject.other | transcription factor Nrf2 | |
| dc.subject.other | transforming growth factor beta | |
| dc.subject.other | translocase of outer mitochondrial membrane 20 | |
| dc.subject.other | tumor necrosis factor | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | adult stem cell | |
| dc.subject.other | antiinflammatory activity | |
| dc.subject.other | ARPE-19 cell line | |
| dc.subject.other | Article | |
| dc.subject.other | cell aging | |
| dc.subject.other | cell survival | |
| dc.subject.other | cell transfer | |
| dc.subject.other | cell viability | |
| dc.subject.other | controlled study | |
| dc.subject.other | down regulation | |
| dc.subject.other | flow cytometry | |
| dc.subject.other | gene expression | |
| dc.subject.other | human | |
| dc.subject.other | human cell | |
| dc.subject.other | human endometrium derived mesenchymal stem cell | |
| dc.subject.other | immunofluorescence | |
| dc.subject.other | immunohistochemistry | |
| dc.subject.other | in vitro study | |
| dc.subject.other | mesenchymal stem cell | |
| dc.subject.other | mitochondrial transfer | |
| dc.subject.other | oxidative stress | |
| dc.subject.other | preclinical study | |
| dc.subject.other | protein expression | |
| dc.subject.other | real time polymerase chain reaction | |
| dc.subject.other | upregulation | |
| dc.subject.other | wet macular degeneration | |
| dc.subject.other | biological model | |
| dc.subject.other | drug effect | |
| dc.subject.other | drug therapy | |
| dc.subject.other | metabolism | |
| dc.subject.other | mitochondrion | |
| dc.subject.other | pathology | |
| dc.subject.other | therapy | |
| dc.title | Therapeutic potential of adult stem cells-derived mitochondria transfer combined with curcumin administration into ARPE-19 cells in age-related macular degeneration model | |
| dc.type | Article | |
| rdl.citation.openalex | 15 | |
| rdl.citation.scopus | 12 | |
| rdl.citation.wos | 12 | |
| rdl.department | Department of Stem Cell, Institute of Health Sciences, Kocaeli University, Kocaeli, Turkey | |
| rdl.department | Center for Stem Cell and Gene Therapies Research and Practice, Kocaeli University, Kocaeli, Turkey | |
| rdl.department | Department of Histology and Embryology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey | |
| rdl.department | Department of Therapy and Rehabilitation, European Vocational School, Kocaeli Health and Technology University, Kocaeli, Turkey | |
| rdl.oa.status | closed | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

